Respiratory diseases: Interim results from new RPL554 trial demonstrates excellent drug tolerability even at highest dose

Verona Pharma plc, the drug development company focused on first-in-class medicines to treat respiratory diseases, has announced encouraging interim results from the first part of a 120...